In summary, LINCRIS regulates the ubiquitination of the crucial m6A reader protein IGF2BP2 and the LINRIS-IGF2BP2-MYC axis might be a promising therapeutic target of CRC. This evidence concerns the gene MYC and colorectal carcinoma.